Eliza A Hawkes, FRACP, MD, MBBS^1,2, Geoffrey Chong, MD^2,3, Charmaine Smith^4*, Sze-Ting Lee^5,6,7*, Leonid Churilov^8*, Joseph McKendrick^9*, William Renwick¹⁰, Piers Blombery, MBBS^11,12*, Niles Elizabeth Nelson, BSc, MBBS^13*, Tineke Fancourt^14*, Joanne Hawking^15*, Wendi Lin^16*, Andrew M Scott^5,6,7*, Allison Barraclough^16*, Joel Wight^16,17,18, Andrew Grigg, MBBS, MD, FRACP, FRCPA^16*, Colm Keane, MD¹⁹, Chun Yew Fong, MBBS, PhD, FRACP, FRCPA^20,21 and Kate Manos, MBBS^16,17

¹Department of Medical Oncology and Haematology, Eastern Health, Box Hill, Australia
²Austin Health and Olivia Newton John Cancer Research Institute, Heidelberg, Australia
³Ballarat Regional Integrated Cancer Centre, Melbourne, VIC, Australia
⁴Cancer Clinical Trials Centre, Olivia Newton-John Cancer & Wellness Centre, Heidelberg, Australia
⁵School of Cancer Medicine, La Trobe University, Melbourne, Australia
⁶Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia
⁷Olivia Newton-John Cancer Research Institute, Melbourne, Australia
⁸Melbourne Brain Centre, Florey Institute of Neuroscience and Mental Health, Melbourne, Australia
⁹Department of Medical Oncology and Haematology, Eastern Health, Melbourne, Australia
¹⁰Department of Haematology, Western Health, Melbourne, Australia
¹¹Department of Pathology, Peter MacCallum Cancer Center, East Melbourne, Australia
¹²Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
¹³Peter MacCallum Cancer Centre, Melbourne, Australia
¹⁴Department of Anatomical Pathology, Austin Health, Melbourne, VIC, Australia
¹⁵Austin Health, Heidelberg, Australia
¹⁶Department of Haematology, Austin Health, Melbourne, Australia
¹⁷University of Melbourne, Melbourne, Australia
¹⁸Townsville University Hospital, Douglas, Australia
¹⁹Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia
²⁰Olivia Newton John Cancer Research Institute, Austin Health, Melbourne, VIC, Australia
²¹Department of Clinical Haematology, Austin Hospital, Melbourne, VIC, Australia

Christopher Melani, MD¹, Rahul Lakhotia, MD¹, Stefania Pittaluga, MD, PhD², Milos D. Miljkovic, MD, MSc¹, James D. Phelan, PhD^1*, Jagan R. Muppidi, MD, PhD^1*, Craig J. Thomas, PhD^3*, Michele Ceribelli, PhD^3*, Frances Anne Tosto, MS^3*, Craig A. Portell, MD⁴, Rafic J. Farah, MD⁵, Seung Tae Lee, MD, PhD^6*, Anna Marie Juanitez, RN^1*, Seth M. Steinberg, PhD^7*, Elaine S. Jaffe, MD², Mark Roschewski, MD⁸, Louis M. Staudt, MD, PhD¹ and Wyndham H. Wilson, MD, PhD¹

¹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
²Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
³Division of Pre-Clinical Innovation Chemistry Technologies, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD
⁴Division of Hematology and Oncology, University of Virginia, Charlottesville, VA
⁵UPMC Hillman Cancer Center, Pittsburgh, PA
⁶University of Maryland, School of Medicine, Marlene & Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD
⁷Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁸Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD

Giuseppe Gritti, MD, PhD^1*, Paula Marlton, MBBS FRACP FRCPA², Tycel J. Phillips, MD³, Christopher Arthur⁴, Rajat Bannerji, MD, PhD⁵, Paolo Corradini⁶, Anna Johnston^7*, John F. Seymour, MBBS⁸, Sam Yuen, MBBS, FRACP, FRCPA⁹, Jamie Hirata¹⁰, Lisa Musick, PharmD, BCPS^11*, Sourish Saha^10*, Brandon Croft^10* and Christopher Flowers, MD, MS¹²

¹ASST Papa Giovanni XXIII, Bergamo, Italy
²University of Queensland, Brisbane, Australia
³University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
⁴Department of Haematology, Royal North Shore Hospital, Sydney, NSW, Australia
⁵Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁶Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
⁷Royal Hobart Hospital (RHH), Hobart, Australia
⁸Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
⁹Calvary Mater Newcastle, Waratah, Australia
¹⁰Genentech, Inc., South San Fransisco, CA
¹¹Genentech, South San Francisco, CA
¹²The Winship Cancer Institute of Emory University, Atlanta, GA

Aravind Ramakrishnan, MD¹, Kirit M. Ardeshna², Connie Lee Batlevi, MD, PhD³, Maria A V Marzolini^4*, Wendy Osborne, MBBS^5*, Eleni Tholouli, MD, MRCPath^6*, Carlos Bachier, MD⁷, Peter A. McSweeney, MD^8*, Elizabeth Budde, MD PhD⁹, Nancy L. Bartlett, MD^10*, Yiyun Zhang, PhD^11*, Muhammad Al-Hajj, PhD, BSc¹², Martin Pule, MD^12*, Simon Thomas, PhD^12*, Maud Jonnaert, PhD^13*, Vijay G R Peddareddigari^12*, Nushmia Z Khokhar, MD¹², Robert Chen, MD¹⁴ and Lazaros J. Lekakis, MD^15*

¹Sarah Cannon Blood Cancer Center at St. David's South Austin Medical Center, Austin, TX
²Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴UCL Cancer Institute, London, United Kingdom
⁵Department of Haematology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
⁶Department of Haematology, Manchester Royal Infirmary, Manchester, United Kingdom
⁷Texas Transplant Institute, Nashville, TN
⁸Colorado Blood Cancer Institute at Presbyterian/St. Luke's Medical Center, Denver, CO
⁹T Cell Therapeutics Research Laboratory, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
¹⁰Washington University School of Medicine Siteman Cancer Center, St. Louis, MO
¹¹Autolus Therapeutics, London, NJ, United Kingdom
¹²Autolus Ltd, London, United Kingdom
¹³Autolus Therapeutics, Basel, Switzerland
¹⁴Autolus Limited, London, United Kingdom
¹⁵Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL

Rui Zhang, MSc^1*, Yuhua Li, MD & PhD², Sanfang Tu, MD & PhD^2*, Rui Huang, MD & PhD^2*, Xun Lai, MD³, Leping Zhang, MD, PhD^4*, Eugene E. Zvonkov, MD, PhD^5*, Valeriy G. Savchenko, MD, PhD⁶, Nelly G Gabeeva, PhD^5*, Yuchen Liu, MSc^1*, Yuchen Li, MSc^1*, Cheng Jiao, MD, PhD^1*, Lan Deng, MD, PhD^2*, Xuan Zhou, MD^2*, Hongyu Zhang, MD, PhD⁷, Wenli Zhang, MD^7* and Lung-Ji Chang, PhD¹

¹Geno-Immune Medical Institute, Shenzhen, China
²Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
³Department of Hematology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China
⁴Department of Hematology, Peking University People's Hospital, Beijing, China
⁵National Research Center for Hematology, Moscow, Russian Federation
⁶National Research Center for Hematology, Moscow, Russian Federation, Moscow, Russian Federation
⁷Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China